Syneos Health, Inc. 是一家合同研究組織,為北美、歐洲、中東和非洲、亞太及拉丁美洲的醫療器械和生物製藥行業提供各種臨床開發服務。公司總部位於北卡羅來納州羅利。
財務指標
營業收入
2026-03-31
$70.09M
2025-09-30
$70.09M
2025-06-30
$65M
2025-03-31
$65M
營業支出
2026-03-31
$16.71M
2025-09-30
$16.71M
2025-06-30
$17.25M
2025-03-31
$17.25M
淨利潤
2026-03-31
-$17M
2025-09-30
-$17M
2025-06-30
-$852K
2025-03-31
-$852K
淨利潤率
2026-03-31
-24.25%
2025-09-30
-24.25%
2025-06-30
-1.31%
2025-03-31
-1.31%
每股收益
2026-03-31
--
2025-09-30
$0.00
2025-06-30
$0.00
2025-03-31
$-1.58
息稅折舊攤銷前利潤
2026-03-31
-$34.79M
2025-09-30
-$32.17M
2025-06-30
$7.12M
2025-03-31
$7.12M
有效稅率
2026-03-31
16.34%
2025-09-30
16.34%
2025-06-30
21.11%
2025-03-31
21.11%
項目
2026-03-31
2025-09-30
2025-06-30
2025-03-31
營業收入
$70.09M
$70.09M
$65M
$65M
營業支出
$16.71M
$16.71M
$17.25M
$17.25M
淨利潤
-$17M
-$17M
-$852K
-$852K
淨利潤率
-24.25%
-24.25%
-1.31%
-1.31%
每股收益
--
$0.00
$0.00
$-1.58
息稅折舊攤銷前利潤
-$34.79M
-$32.17M
$7.12M
$7.12M
有效稅率
16.34%
16.34%
21.11%
21.11%
常見問題
INCR stock represents shares of Intercure Ltd., an Israel-based company focused on the medical cannabis and consumer wellness sector. The ticker trades on the Nasdaq under the symbol INCR and gives investors exposure to a company involved in the research, cultivation, production, and distribution of cannabis-based products. Its share price, volume, and market data are updated throughout the trading day, so the most current figures are shown on the quote section of this page.
INCR operates in the healthcare and consumer products space, specifically within the medical cannabis industry. The company develops, produces, and sells cannabis-derived products for medical and wellness use, subject to the regulations of the markets in which it operates. Because the cannabis sector is relatively young and heavily regulated, industry conditions, licensing rules, and legal developments can play a meaningful role in how INCR is viewed by investors.
Recent price action for INCR, including its latest closing price, daily change, and short-term trend, is displayed in the quote and chart sections on this page. Performance can vary considerably over days, weeks, and months, so reviewing the updated percentage moves and trading volume is the most reliable way to gauge how the stock has behaved recently rather than relying on a fixed figure.
Valuation analysis for INCR typically involves comparing its stock price with underlying financial fundamentals such as revenue, earnings, cash flow, and book value. Price-to-sales, price-to-earnings, and price-to-book are common metrics, but their usefulness depends on the company's profitability and growth stage. Investors often compare INCR with industry peers and review its market capitalization to put the valuation in context, noting that young cannabis companies can be difficult to value on traditional metrics.
INCR can be traded during regular U.S. market hours, which are typically 9:30 a.m. to 4:00 p.m. Eastern Time on weekdays when the Nasdaq is open. Some brokers also offer pre-market and after-hours sessions, though liquidity is usually thinner and price swings can be wider. Trading is not available on weekends or market holidays, so orders placed outside open hours are queued for the next session.
INCR is exposed to risks common to cannabis-related companies, including regulatory changes, licensing requirements, taxation, and limited access to certain banking or capital markets. As a smaller company, it may also face higher share price volatility, competition, and dependency on key markets or products. Currency exposure and geopolitical factors associated with its international operations can add further uncertainty. These risks can influence revenue, costs, and the market's overall valuation of the shares.